NEW YORK, Oct. 13, 2023 /PRNewswire/ -- L Catterton and Thorne HealthTech, Inc. ('Thorne') (NASDAQ: THRN) today announced that the tender offer to purchase all of the issued and outstanding shares of Thorne's common stock ('Shares') for $10.20 per Share, net to the seller in cash, without interest and less any required withholding taxes (the 'Offer'), expired as scheduled at one minute past 11:59 p.m., Eastern Time, on October 12, 2023 and was not extended (such date and time, the 'Expiration Time')..

纽约，2023年10月13日/PRNewswire/--L Catterton和Thorne HealthTech，Inc。（'Thorne'）（纳斯达克股票代码：THRN）今天宣布购买Thorne所有已发行和已发行股份的投标股票（'股份'），每股10.20美元，净价给卖方现金，无利息，减少任何所需的扣税（'报价'），于2023年10月12日东部时间晚上11:59一分钟到期，未延期（此类日期和时间，“到期时间”）。。

Computershare Trust Company, N.A., the depositary and paying agent for the Offer, has advised L Catterton that, as of the Expiration Time, 52,596,517 Shares were validly tendered and not validly withdrawn in the Offer, representing 97.3% of the issued and outstanding Shares as of the Expiration Time.

Computershare Trust Company，N.A。是该优惠的存款人和支付代理人，已告知L Catterton，截至到期时间，该优惠中有52596517股股票被有效投标，未有效撤回，占已发行和已发行股份的97.3%。到期时间。

Accordingly, all conditions to the Offer have been satisfied. L Catterton and its affiliate, Healthspan Merger Sub, Inc. ('Purchaser'), will promptly accept for payment, and will promptly pay for, all Shares validly tendered and not validly withdrawn in the Offer..

因此，报价的所有条件都得到满足。L Catterton及其附属公司Healthspan Merger Sub，Inc。（'购买者'）将立即接受付款，并将立即支付所有有效投标且未有效撤回报价的股份。。

The parties expect to consummate the acquisition on October 16, 2023, in accordance with, and subject to the terms of, the definitive agreement for the proposed acquisition.

双方希望根据拟议收购的最终协议，并在其条款的约束下，于2023年10月16日完成收购。

Advisors

顾问

BofA Securities served as financial advisor and Kirkland & Ellis LLP served as legal advisor to L Catterton. CG Sawaya Partners (operating under Canaccord Genuity) served as exclusive financial advisor and Wilson Sonsini Goodrich & Rosati served as legal advisor to Thorne and Thorne's Special Committee of the Board of Directors..

BofA证券担任财务顾问，Kirkland＆Ellis LLP担任L Catterton的法律顾问。CG Sawaya合作伙伴（在Canaccord Genuity下运营）担任独家财务顾问，Wilson Sonsini Goodrich＆Rosati担任Thorne和Thorne董事会特别委员会的法律顾问。。

About L Catterton

关于L卡特顿

L Catterton is a market-leading consumer-focused investment firm, managing approximately $34 billion of equity capital and three multi-product platforms: private equity, credit, and real estate. Leveraging deep category insight, operational excellence, and a broad network of strategic relationships, L Catterton's team of more than 200 investment and operating professionals across 17 offices partners with management teams to drive differentiated value creation across its portfolio.

L Catterton是一家市场领先的以消费者为中心的投资公司，管理约340亿美元的股权和三个多产品平台：私募股权，信贷和房地产。利用深层次的洞察力，卓越的运营运营和广泛的战略关系网络，卡特顿的团队由17个办公室合作伙伴的200多名投资和运营专业人员与管理团队共同推动其投资组合中的差异化价值创造。

Founded in 1989, the firm has made over 250 investments in some of the world's most iconic consumer brands. For more information about L Catterton, please visit www.lcatterton.com. .

该公司成立于1989年，已对世界上一些最具标志性的消费品牌进行了250多项投资。有关L Catterton的更多信息，请访问www.lcatterton.com。

About Thorne HealthTech, Inc.

关于Thorne HealthTech，Inc。

Thorne is a leader in developing innovative solutions for delivering personalized approaches to health and wellness. As a science-driven wellness company that empowers individuals with the support, education, and solutions they need to achieve healthy aging – living healthier longer – Thorne utilizes testing and data to create improved product efficacy and to deliver personalized solutions to consumers, health professionals, and corporations.

Thorne是开发创新解决方案的领导者，为健康和健康提供个性化方法。作为一家以科学为导向的健康公司，为个人提供实现健康老龄化所需的支持，教育和解决方案-更健康，更健康-Thorne利用测试和数据提高产品效率，并为消费者，卫生专业人员提供个性化解决方案，和公司。

Predicated on the power of the individual, Thorne leverages artificial intelligence models to provide insights and personalized data, products, and services that help individuals take a proactive and actionable approach to improve and maintain their health over a lifetime. Thorne is the only supplement manufacturer that collaborates with Mayo Clinic on health and wellness research and content and is trusted by more than five million customers, 47,000+ health-care professionals, thousands of professional athletes, more than 100 professional sports teams, and multiple U.S.

基于个人的力量，Thorne利用人工智能模型提供见解和个性化数据，产品和服务，帮助个人采取积极可行的方法来改善和维持一生的健康。Thorne是唯一一家与Mayo Clinic合作进行健康与健康研究和内容的补充制造商，受到500多万客户，47000多名医疗保健专业人员，数千名专业运动员，100多名专业运动队和多名美国员工的信任。

National Teams. For more information, visit www.thorne.com..

国家队。欲了解更多信息，请访问www.thorne.com。。

Additional Information and Where to Find It

其他信息以及在哪里找到它

This communication is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell any securities, nor is it a substitute for the tender offer materials that affiliates of L Catterton, including Purchaser, filed with the U.S. Securities and Exchange Commission (the 'SEC').

本通信仅供参考，既不是购买报价，也不是征求出售任何证券，也不是替代L Catterton附属公司（包括购买者）向美国证券交易委员会（“SEC”）提交的投标报价材料。

The solicitation and offer to buy outstanding Shares of Thorne was only made pursuant to the tender offer materials that affiliates of L Catterton, including Purchaser, filed with the SEC. The tender offer materials are available for free on the SEC's website at www.sec.gov. .

购买Thorne已发行股份的征求和报价仅根据L Catterton的附属公司（包括购买者）向SEC提交的投标报价材料进行。投标报价材料可在SEC网站www.SEC免费获取。.gov。

Forward-Looking Statements

前瞻性声明

This communication contains forward-looking statements. All statements other than statements of historical facts contained in this communication are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as 'may,' 'will,' 'should,' 'would,' 'expect,' 'plan,' 'anticipate,' 'could,' 'intend,' 'target,' 'project,' 'contemplate,' 'believe,' 'estimate,' 'predict,' 'potential' or 'continue' or the negative of these terms or other similar expressions.

本通讯包含前瞻性陈述。本通讯中包含的除历史事实陈述以外的所有陈述均为前瞻性陈述。在某些情况下，您可以通过“可能”，“将会”，“应该”，“将会”，“预期”，“计划”，“预期”，“可能”，“打算”，“目标“，”项目“，”沉思“，”相信“，”估计“，”预测“，”潜在“或”继续“或这些术语或其他类似表达式的否定。

Forward-looking statements contained in this communication include, but are not limited to, statements regarding Thorne's pending acquisition by affiliates of L Catterton (the 'Transaction'), including the expected timing of the closing of the Transaction. These forward-looking statements involve risks and uncertainties.

本通讯中包含的前瞻性声明包括但不限于有关Thorne待L Catterton关联公司收购（“交易”）的待决声明，包括交易结束的预期时间。这些前瞻性陈述涉及风险和不确定性。

If any of these risks or uncertainties materialize, or if any assumptions prove incorrect, actual results could differ materially from the results expressed or implied by these forward-looking statements. These risks and uncertainties include risks associated with potential litigation relating to the Transaction; uncertainties as to the timing of the consummation of the Transaction and the ability of each party to consummate the Transaction; and the risks and uncertainties described in the section titled 'Risk Factors' and elsewhere in Thorne's filings made with the SEC, including its Annual Report on Form 10-K filed on March 31, 2023, and its subsequent Quarterly Reports on Form 10-Q and other SEC filings, copies of which are available free of charge on the SEC's website at www.sec.gov.

如果实现这些风险或不确定性中的任何一个，或者如果任何假设证明不正确，实际结果可能与这些前瞻性陈述所表达或暗示的结果大不相同。这些风险和不确定性包括与交易相关的潜在诉讼相关的风险；交易完成的时间和各方完成交易的能力存在不确定性；以及在题为“风险因素”一节和Thorne向SEC提交的文件中的其他部分所述的风险和不确定性，包括其于2023年3月31日提交的10-K表格年度报告以及随后的10-Q表格季度报告和其他SEC文件，其副本可在SEC网站www.SEC.gov上免费获取。

Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking sta.

由于前瞻性陈述固有地受到风险和不确定性的影响，其中一些风险和不确定性无法预测或量化，因此不应依赖这些前瞻性陈述。

SOURCE Thorne HealthTech, Inc.

来源Thorne HealthTech，Inc。